DASA selects AGFA HealthCare’s imaging platform for Latin American network

Published 01/07/2025, 09:02
DASA selects AGFA HealthCare’s imaging platform for Latin American network

MORTSEL, BELGIUM - DASA (Diagnósticos da América S.A.), Latin America’s largest diagnostic provider, has chosen AGFA HealthCare’s Enterprise Imaging Platform to unify its imaging IT ecosystem, according to a press release issued Tuesday.

The agreement will replace five legacy systems with a single integrated platform across DASA’s extensive healthcare network in Brazil and Argentina, which encompasses more than 40 healthcare provider brands.

DASA, which operates 321 branches across Brazil and delivers over 15.2 million clinical studies annually, made the decision following demonstrations at healthcare conferences and reference site visits to customers in Chile where they observed the platform’s clinical and operational benefits.

Implementation of the platform has begun in a phased approach, with plans for potential expansion across DASA’s entire network in 2025, which could support up to 15 million studies annually.

The selection comes after DASA and Amil created a joint venture in 2024 that consolidated 25 hospitals and over 4,400 beds, making DASA the second largest hospital group in Brazil.

"Our renewed presence in Brazil, and strong market reputation in Latin America, has instilled deep confidence in our Enterprise Imaging Platform," said Silvio Selvaggio, Regional President for Latin America at AGFA HealthCare.

AGFA HealthCare’s local partner, Konimagem, played a significant role in securing the agreement through their understanding of the Brazilian healthcare landscape and engagement with DASA.

The Enterprise Imaging Platform offers capabilities including pixel streaming, workflow orchestration, augmented intelligence, interoperability, and cloud deployment, which aim to provide radiologists with improved image fidelity and collaboration tools.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.